期刊文献+

北京市癌痛控制20年进步与挑战——北京市多中心癌痛状况调查(FENPAI4090) 被引量:104

PROGRESS AND CHALLENGES IN PAIN MANAGEMENT IN BEIJING IN LAST 20 YEARS——MULTICENTER INVESTIGATION OF CANCER PAIN MANAGEMENT IN BEIJING(FENPAI4090)
在线阅读 下载PDF
导出
摘要 目的:通过北京市多中心癌痛状况调查,了解北京市癌痛控制现状。方法:采用问卷调查的方法对北京地区11家医院的477例患者和217名医师调查。统计分析使用SAS 9.1.3软件、采取双侧检验方法,并与1992年调查结果进行比较。结果:中重度癌痛患者仍有较高比例(65.82%);但强阿片类药物的使用比例已经明显提高(占48.85%);医患双方对癌痛知识的了解都有待进一步提高;医患对阿片类药物使用的主要顾虑是担心"成瘾"。结论:北京地区癌痛控制二十年来有明显发展,包括阿片类药物应用比例升高,医师对阿片类药物不良反应关注度提高等;但针对癌痛控制存在的问题,医师培训和患者教育仍是推动癌痛控制的重要任务。 Objective: To understand the current status of cancer pain management in Beijing by means of multicenter investigation. Methods: Totally 477 cancer patients and 217 doctors in 11 hospitals in Beijing were involved in the questionnaire investigation. Statistical analysis was conducted with the software SAS 9.1.3 by two-sided test. The results were compared with the investigation in 1992. Results: There was still a higher proportion of moderate and severe pain (65.82%). Usage proportion of strong opioids was obviously increased (48.85%). Both patients and doctors needed to improve their knowledge of cancer pain. The main concern of patients and doctors about use of opioids was addiction. Conclusions: There is a significant development of cancer pain management in Beijing in last 20 years, such as increased usage proportion of opioids and increased attention of doctors to the adverse reactions of opioids. In regard to problems existing in cancer pain management, doctor training and patient education are still the main task in improving cancer pain management.
出处 《中国疼痛医学杂志》 CAS CSCD 北大核心 2014年第1期5-12,17,共9页 Chinese Journal of Pain Medicine
关键词 癌痛 阿片药物 疼痛控制 Cancer pain Opioid Pain management
作者简介 通讯作者lppmal23@sina.com
  • 相关文献

参考文献9

  • 1Cohen MZ, Easley MK, Ellis C, et al. Cancer pain management and the JCAHO' s pain standards: an institutional challenge. J Pain Symptom Manag, 2003, 25:519 - 527.
  • 2Goudas LC, Bloch R, Gialeli-Goudas M, et al. The epidemiology of cancer pain. Cancer Inves, 2005, 23:182 190.
  • 3Svendsen KB, Andersen S, Arnason S, et al. Break-through pain in malignant and non-malignant dise-ases: a review of prevalence, characteristics and mechanisms. Eur J Pain, 2005, 9:195 - 206.
  • 4高寿征,孙瑞忠,王欣,等.北京地区215例癌痛的调查分析.北京医学,1992,14:381.
  • 5京市癌痛与姑息治疗协作组,刘淑俊,聂军,田敬东,朱允中,李湘虎,杨莹,张建军,李庆琪,赵玉亮,贾廷珍,曹阳,杨雨霏,赵启成,宛凤玲,蒋敏,徐光炜.北京市219位医生对癌痛控制的看法[J].中国肿瘤,1999,8(2):61-63. 被引量:5
  • 6蔡志基,赵雩卿,刘端祺.国际麻醉药品的医疗消耗趋势[J].医学与哲学(B),2007,28(12):17-18. 被引量:10
  • 7Wang XS, Mendoza TR, Gao SZ, et al. The Chin- ese version of the brief pain inventory (BPI-C): its development and use in a study of cancer pain. Pain, 1996, 67:407 - 416.
  • 8Xin SW, Charles SC, Tito RM, et al. The effects of pain severity on health-related quality of life. Cancer, 1999, 86:1848 - 1855.
  • 9Portenoy RK, Ganae-Motan ED, Allende S, et al. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, plac-ebo- controlled, graded-dose trial. J Pain, 2012, 13:438 - 449.

共引文献13

同被引文献915

引证文献104

二级引证文献995

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部